TIDMHIK

RNS Number : 5260N

Hikma Pharmaceuticals Plc

20 May 2020

Hikma Pharmaceuticals PLC - EIP Vesting

LONDON, 20 May 2020: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 16 May 2018 under the 2014 Executive Incentive Plan ("EIP") Element B which was completed on 19 May 2020.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from vesting of the conditional 
       transaction               awards on 
                                 18 May 2020 under the 2014 EIP Element B. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 16,953 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   19 May 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Riad Mishlawi

 
1   Details of the person discharging managerial responsibilities 
     / person closely associated 
a)  Name                     Riad Mishlawi 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            Shares acquired from vesting of the conditional 
     transaction              awards on 
                              18 May 2020 under the 2014 EIP Element B. 
c)  Price(s) and             Price(s): GBPnil 
     volume(s)                Volume(s): 22,601 
d)  Aggregated information   N/A 
e)  Date of the transaction  19 May 2020 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Majda Labadi

 
1   Details of the person discharging managerial responsibilities 
     / person closely associated 
a)  Name                     Majda Labadi 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            Shares acquired from vesting of the conditional 
     transaction              awards on 
                              18 May 2020 under the 2014 EIP Element B. 
c)  Price(s) and             Price(s): GBPnil 
     volume(s)                Volume(s): 15,855 
d)  Aggregated information   N/A 
e)  Date of the transaction  19 May 2020 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Bassam Kanaan

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Bassam Kanaan 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the            Shares acquired from vesting of the conditional 
       transaction              awards on 
                                18 May 2020 under the 2014 EIP Element B. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 25,729 
 d)   Aggregated information    N/A 
 e)   Date of the transaction  19 May 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Khalid Nabilsi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Khalid Nabilsi 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from vesting of the conditional 
       transaction               awards on 
                                 18 May 2020 under the 2014 EIP Element B. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 23,062 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   19 May 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Brian Hoffmann

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Brian Hoffmann 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from vesting of the conditional 
       transaction               awards on 
                                 18 May 2020 under the 2014 EIP Element B. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 18,247 
 d)   Aggregated information    N/A 
 e)   Date of the transaction   19 May 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Hussein Arkhagha

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Hussein Arkhagha 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Disposal of Shares acquired from vesting of 
       transaction               the conditional awards on 18 May 2020 under 
                                 the 2014 EIP Element B. 
 c)   Price(s) and              Price(s): GBP24.629 
       volume(s)                 Volume(s): 13,489 
 d)   Aggregated information    Aggregated volume: 13,489 
                                 Price: GBP332,220.58 
 e)   Date of the transaction   19 May 2020 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBSGDUGSDDGGG

(END) Dow Jones Newswires

May 20, 2020 10:42 ET (14:42 GMT)

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Hikma Pharmaceuticals
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Hikma Pharmaceuticals